SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-009722
Filing Date
2023-03-24
Accepted
2023-03-24 16:04:48
Documents
12
Period of Report
2023-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sctl-20230323.htm   iXBRL 8-K 49569
  Complete submission text file 0000950170-23-009722.txt   162517

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sctl-20230323_pre.xml EX-101.PRE 9461
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sctl-20230323.xsd EX-101.SCH 2481
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sctl-20230323_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20230323_htm.xml XML 4513
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 23759865
SIC: 2834 Pharmaceutical Preparations